位置:首页 > 蛋白库 > PREX2_HUMAN
PREX2_HUMAN
ID   PREX2_HUMAN             Reviewed;        1606 AA.
AC   Q70Z35; B4DFX0; Q32KL0; Q32KL1; Q6R7Q3; Q6R7Q4; Q9H805; Q9H961;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 149.
DE   RecName: Full=Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein {ECO:0000305};
DE            Short=P-Rex2;
DE            Short=PtdIns(3,4,5)-dependent Rac exchanger 2;
DE   AltName: Full=DEP domain-containing protein 2;
GN   Name=PREX2 {ECO:0000312|HGNC:HGNC:22950}; Synonyms=DEPDC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, and Skeletal muscle;
RX   PubMed=15304343; DOI=10.1016/j.febslet.2004.06.096;
RA   Donald S., Hill K., Lecureuil C., Barnouin R., Krugmann S.,
RA   John Coadwell W., Andrews S.R., Walker S.A., Hawkins P.T., Stephens L.R.,
RA   Welch H.C.E.;
RT   "P-Rex2, a new guanine-nucleotide exchange factor for Rac.";
RL   FEBS Lett. 572:172-176(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Mammary gland;
RA   Joseph R.E., Norris F.A.;
RT   "Cloning and characterization of P-Rex2: an inositol polyphosphate 4-
RT   phosphatase domain containing guanine nucleotide exchange factor.";
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 33-1606 (ISOFORM 4), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 216-1588 (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 549-1588 (ISOFORM 1).
RC   TISSUE=Embryo, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   IDENTIFICATION (ISOFORM 3), FUNCTION, AND ALTERNATIVE SPLICING.
RX   PubMed=15304342; DOI=10.1016/j.febslet.2004.06.097;
RA   Rosenfeldt H., Vazquez-Prado J., Gutkind J.S.;
RT   "P-REX2, a novel PI-3-kinase sensitive Rac exchange factor.";
RL   FEBS Lett. 572:167-171(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=15897194; DOI=10.1074/jbc.m412495200;
RA   Joseph R.E., Norris F.A.;
RT   "Substrate specificity and recognition is conferred by the pleckstrin
RT   homology domain of the Dbl family guanine nucleotide exchange factor P-
RT   Rex2.";
RL   J. Biol. Chem. 280:27508-27512(2005).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-537 AND GLU-1571.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Functions as a RAC1 guanine nucleotide exchange factor (GEF),
CC       activating Rac proteins by exchanging bound GDP for free GTP. Its
CC       activity is synergistically activated by phosphatidylinositol 3,4,5-
CC       trisphosphate and the beta gamma subunits of heterotrimeric G protein.
CC       Mediates the activation of RAC1 in a PI3K-dependent manner. May be an
CC       important mediator of Rac signaling, acting directly downstream of both
CC       G protein-coupled receptors and phosphoinositide 3-kinase.
CC       {ECO:0000269|PubMed:15304342, ECO:0000269|PubMed:15304343,
CC       ECO:0000269|PubMed:15897194}.
CC   -!- SUBUNIT: Interacts with RAC1.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=P-Rex2;
CC         IsoId=Q70Z35-1; Sequence=Displayed;
CC       Name=3;
CC         IsoId=Q70Z35-3; Sequence=VSP_025150, VSP_025152;
CC       Name=4;
CC         IsoId=Q70Z35-4; Sequence=VSP_055612, VSP_055613, VSP_055614;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is highly expressed in skeletal muscle,
CC       heart and placenta, absent from peripheral blood leukocytes. Isoform 2
CC       is expressed in skeletal muscle, kidney, small intestine, and placenta.
CC       Isoform 3 is expressed in the heart. {ECO:0000269|PubMed:15304343}.
CC   -!- DOMAIN: PH domain confers substrate specificity and recognition. Able
CC       to discriminate between RAC1, RHOA, and CDC42.
CC   -!- DOMAIN: DH domain alone was unable to confer substrate specificity and
CC       recognition.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AK024079; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAB14375.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAG57581.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=DAA05334.1; Type=Miscellaneous discrepancy; Note=Non-canonical splice intron-exon junction.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ437636; CAD26885.2; -; mRNA.
DR   EMBL; AY508996; AAS82571.1; -; mRNA.
DR   EMBL; AY508997; AAS82572.1; -; mRNA.
DR   EMBL; AC011853; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103783; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104416; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK023049; BAB14375.1; ALT_INIT; mRNA.
DR   EMBL; AK024079; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK294299; BAG57581.1; ALT_INIT; mRNA.
DR   EMBL; BK005160; DAA05333.1; -; mRNA.
DR   EMBL; BK005161; DAA05334.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS6201.1; -. [Q70Z35-1]
DR   RefSeq; NP_079146.2; NM_024870.3. [Q70Z35-1]
DR   RefSeq; NP_079446.3; NM_025170.5. [Q70Z35-3]
DR   PDB; 6BNM; X-ray; 1.90 A; A=219-377.
DR   PDBsum; 6BNM; -.
DR   AlphaFoldDB; Q70Z35; -.
DR   SMR; Q70Z35; -.
DR   BioGRID; 123199; 15.
DR   IntAct; Q70Z35; 7.
DR   STRING; 9606.ENSP00000288368; -.
DR   GlyGen; Q70Z35; 1 site, 1 N-linked glycan (1 site).
DR   iPTMnet; Q70Z35; -.
DR   PhosphoSitePlus; Q70Z35; -.
DR   BioMuta; PREX2; -.
DR   DMDM; 74758897; -.
DR   EPD; Q70Z35; -.
DR   jPOST; Q70Z35; -.
DR   MassIVE; Q70Z35; -.
DR   MaxQB; Q70Z35; -.
DR   PaxDb; Q70Z35; -.
DR   PeptideAtlas; Q70Z35; -.
DR   PRIDE; Q70Z35; -.
DR   ProteomicsDB; 68577; -. [Q70Z35-1]
DR   ProteomicsDB; 68579; -. [Q70Z35-3]
DR   Antibodypedia; 2764; 70 antibodies from 15 providers.
DR   DNASU; 80243; -.
DR   Ensembl; ENST00000288368.5; ENSP00000288368.4; ENSG00000046889.19. [Q70Z35-1]
DR   GeneID; 80243; -.
DR   KEGG; hsa:80243; -.
DR   MANE-Select; ENST00000288368.5; ENSP00000288368.4; NM_024870.4; NP_079146.2.
DR   UCSC; uc003xxv.2; human. [Q70Z35-1]
DR   CTD; 80243; -.
DR   DisGeNET; 80243; -.
DR   GeneCards; PREX2; -.
DR   HGNC; HGNC:22950; PREX2.
DR   HPA; ENSG00000046889; Tissue enhanced (brain).
DR   MIM; 612139; gene.
DR   neXtProt; NX_Q70Z35; -.
DR   OpenTargets; ENSG00000046889; -.
DR   PharmGKB; PA164725103; -.
DR   VEuPathDB; HostDB:ENSG00000046889; -.
DR   eggNOG; KOG3519; Eukaryota.
DR   eggNOG; KOG4428; Eukaryota.
DR   GeneTree; ENSGT00940000155894; -.
DR   HOGENOM; CLU_003935_0_0_1; -.
DR   InParanoid; Q70Z35; -.
DR   OMA; VRQYNQK; -.
DR   OrthoDB; 24217at2759; -.
DR   PhylomeDB; Q70Z35; -.
DR   TreeFam; TF328639; -.
DR   PathwayCommons; Q70Z35; -.
DR   Reactome; R-HSA-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   SignaLink; Q70Z35; -.
DR   SIGNOR; Q70Z35; -.
DR   BioGRID-ORCS; 80243; 15 hits in 1070 CRISPR screens.
DR   ChiTaRS; PREX2; human.
DR   GeneWiki; PREX2; -.
DR   GenomeRNAi; 80243; -.
DR   Pharos; Q70Z35; Tbio.
DR   PRO; PR:Q70Z35; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q70Z35; protein.
DR   Bgee; ENSG00000046889; Expressed in calcaneal tendon and 161 other tissues.
DR   Genevisible; Q70Z35; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:MGI.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IDA:MGI.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:MGI.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; IEA:Ensembl.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   CDD; cd04439; DEP_1_P-Rex; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.10.10.10; -; 2.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 2.30.42.10; -; 2.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000591; DEP_dom.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR037367; Rex2_DEP_1.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00610; DEP; 2.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00049; DEP; 2.
DR   SMART; SM00228; PDZ; 2.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF46785; SSF46785; 2.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF50156; SSF50156; 2.
DR   PROSITE; PS50186; DEP; 2.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50106; PDZ; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Guanine-nucleotide releasing factor;
KW   Reference proteome; Repeat.
FT   CHAIN           1..1606
FT                   /note="Phosphatidylinositol 3,4,5-trisphosphate-dependent
FT                   Rac exchanger 2 protein"
FT                   /id="PRO_0000286795"
FT   DOMAIN          23..214
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          245..361
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          390..464
FT                   /note="DEP 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00066"
FT   DOMAIN          491..566
FT                   /note="DEP 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00066"
FT   DOMAIN          592..671
FT                   /note="PDZ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          677..754
FT                   /note="PDZ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   REGION          1581..1606
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         48..112
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055612"
FT   VAR_SEQ         906..979
FT                   /note="FSRVLKNRAWPTFKQAKSKISPLHSSDFCPTNCHVNVMEVSYPKTSTSLGSA
FT                   FGVQLDSRKHNSHDKENKSSEQ -> VQASERFYNFTARHAVWEHSFDLHSVSSTFPVP
FT                   VTMEFLLLPPPLLGISQDGRQHCIPEDLPSQEMLLAERAPV (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2"
FT                   /id="VSP_025150"
FT   VAR_SEQ         980..1606
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2"
FT                   /id="VSP_025152"
FT   VAR_SEQ         1049
FT                   /note="D -> E (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055613"
FT   VAR_SEQ         1050..1606
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055614"
FT   VARIANT         312
FT                   /note="D -> N (in dbSNP:rs11784582)"
FT                   /id="VAR_032163"
FT   VARIANT         537
FT                   /note="V -> I (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs147538692)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035973"
FT   VARIANT         1571
FT                   /note="A -> E (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035974"
FT   CONFLICT        158
FT                   /note="T -> I (in Ref. 2; AAS82571/AAS82572)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1076
FT                   /note="E -> V (in Ref. 2; AAS82571 and 4; AK024079)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1268
FT                   /note="C -> R (in Ref. 2; AAS82571)"
FT                   /evidence="ECO:0000305"
FT   HELIX           219..229
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   HELIX           239..241
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   STRAND          246..256
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   STRAND          259..268
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   STRAND          271..276
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   STRAND          294..301
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   STRAND          305..309
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   STRAND          314..316
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   STRAND          322..332
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   TURN            333..336
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   STRAND          337..342
FT                   /evidence="ECO:0007829|PDB:6BNM"
FT   HELIX           346..364
FT                   /evidence="ECO:0007829|PDB:6BNM"
SQ   SEQUENCE   1606 AA;  182622 MW;  D9E938D65CE2C7DD CRC64;
     MSEDSRGDSR AESAKDLEKQ LRLRVCVLSE LQKTERDYVG TLEFLVSAFL HRMNQCAASK
     VDKNVTEETV KMLFSNIEDI LAVHKEFLKV VEECLHPEPN AQQEVGTCFL HFKDKFRIYD
     EYCSNHEKAQ KLLLELNKIR TIRTFLLNCM LLGGRKNTDV PLEGYLVTPI QRICKYPLIL
     KELLKRTPRK HSDYAAVMEA LQAMKAVCSN INEAKRQMEK LEVLEEWQSH IEGWEGSNIT
     DTCTEMLMCG VLLKISSGNI QERVFFLFDN LLVYCKRKHR RLKNSKASTD GHRYLFRGRI
     NTEVMEVENV DDGTADFHSS GHIVVNGWKI HNTAKNKWFV CMAKTPEEKH EWFEAILKER
     ERRKGLKLGM EQDTWVMISE QGEKLYKMMC RQGNLIKDRK RKLTTFPKCF LGSEFVSWLL
     EIGEIHRPEE GVHLGQALLE NGIIHHVTDK HQFKPEQMLY RFRYDDGTFY PRNEMQDVIS
     KGVRLYCRLH SLFTPVIRDK DYHLRTYKSV VMANKLIDWL IAQGDCRTRE EAMIFGVGLC
     DNGFMHHVLE KSEFKDEPLL FRFFSDEEME GSNMKHRLMK HDLKVVENVI AKSLLIKSNE
     GSYGFGLEDK NKVPIIKLVE KGSNAEMAGM EVGKKIFAIN GDLVFMRPFN EVDCFLKSCL
     NSRKPLRVLV STKPRETVKI PDSADGLGFQ IRGFGPSVVH AVGRGTVAAA AGLHPGQCII
     KVNGINVSKE THASVIAHVT ACRKYRRPTK QDSIQWVYNS IESAQEDLQK SHSKPPGDEA
     GDAFDCKVEE VIDKFNTMAI IDGKKEHVSL TVDNVHLEYG VVYEYDSTAG IKCNVVEKMI
     EPKGFFSLTA KILEALAKSD EHFVQNCTSL NSLNEVIPTD LQSKFSALCS ERIEHLCQRI
     SSYKKFSRVL KNRAWPTFKQ AKSKISPLHS SDFCPTNCHV NVMEVSYPKT STSLGSAFGV
     QLDSRKHNSH DKENKSSEQG KLSPMVYIQH TITTMAAPSG LSLGQQDGHG LRYLLKEEDL
     ETQDIYQKLL GKLQTALKEV EMCVCQIDDL LSSITYSPKL ERKTSEGIIP TDSDNEKGER
     NSKRVCFNVA GDEQEDSGHD TISNRDSYSD CNSNRNSIAS FTSICSSQCS SYFHSDEMDS
     GDELPLSVRI SHDKQDKIHS CLEHLFSQVD SITNLLKGQA VVRAFDQTKY LTPGRGLQEF
     QQEMEPKLSC PKRLRLHIKQ DPWNLPSSVR TLAQNIRKFV EEVKCRLLLA LLEYSDSETQ
     LRRDMVFCQT LVATVCAFSE QLMAALNQMF DNSKENEMET WEASRRWLDQ IANAGVLFHF
     QSLLSPNLTD EQAMLEDTLV ALFDLEKVSF YFKPSEEEPL VANVPLTYQA EGSRQALKVY
     FYIDSYHFEQ LPQRLKNGGG FKIHPVLFAQ ALESMEGYYY RDNVSVEEFQ AQINAASLEK
     VKQYNQKLRA FYLDKSNSPP NSTSKAAYVD KLMRPLNALD ELYRLVASFI RSKRTAACAN
     TACSASGVGL LSVSSELCNR LGACHIIMCS SGVHRCTLSV TLEQAIILAR SHGLPPRYIM
     QATDVMRKQG ARVQNTAKNL GVRDRTPQSA PRLYKLCEPP PPAGEE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024